Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,861,399
-
Share change
-
-274,484
-
Total reported value
-
$23,444,000
-
Price per share
-
$4.00
-
Number of holders
-
29
-
Value change
-
-$1,111,881
-
Number of buys
-
5
-
Number of sells
-
17
Institutional Holders of KEMPHARM INC - COM (KMPH) as of Q2 2017
As of 30 Jun 2017,
KEMPHARM INC - COM (KMPH) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,861,399 shares.
The largest 10 holders included
DSC Advisors, L.P., Alyeska Investment Group, L.P., Arete Wealth Advisors, LLC, DEERFIELD MANAGEMENT CO, Creative Planning, C WorldWide Group Holding A/S, VANGUARD GROUP INC, FEDERATED INVESTORS INC /PA/, VICTORY CAPITAL MANAGEMENT INC, and Parkwood LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.